Faculty Detail   
Name SHUKO HARADA
 
Campus Address NP 3540 Zip 6823
Phone  (205) 996-5848
E-mail  sharada@uabmc.edu
Other websites
    

 Education

Medical School  University of Tokyo Faculty of Medicine, Tokyo, Japan    1985  M.D. 

 Certifications

American Board of Pathology, Anatomic and Clinical  2008 
Molecular Genetic Pathology  2011 

Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Genomic Diagnostics & Bioinformatics  Genomic Diagnostics & Bioinformatics Professor
Center  Comprehensive Cancer Center  Comprehensive Cancer Center Professor

Biographical Sketch 
Dr. Harada received her medical degree from the University of Tokyo Faculty of Medicine and completed her residency training for Internal Medicine, worked as an internist in Endocrinology and Metabolism in Tokyo, Japan. She moved to USA and conducted research on insulin signal transduction and gene regulation at University of Pennsylvania, a part of which as a research faculty. She completed her residency at Drexel University College of Medicine followed by surgical pathology and molecular genetic pathology fellowship at University of Pennsylvania and Johns Hopkins University, respectively. She joined the faculty at UAB in August, 2011. Dr. Harada is board certified in Anatomic and Clinical Pathology as well as Molecular Genetic Pathology. Currently she is Head of Molecular Diagnostic Laboratory, which offers wide variety of molecular and genomic testing for infectious diseases and oncology including next generation sequencing analysis. She has particular interests in precision medicine in oncology and pharmacogenomics, and a member of Precision Medicine Institute and Comprehensive Cancer Center.

Society Memberships
Organization Name Position Held Org Link
AMP (Association for Molecular Pathology)  member   
Association of Clinical Scientists (ACS)  fellow member   
College of American Pathologists   fellow member   
United States and Canadian Academy of Pathology  member   
 

Research/Clinical Interest
Title
Molecular Profiling of Breast ductal carcinoma in situ; Implementation of next generation sequencing into precision medicine
Description
My research interests are following; 1. Clinical implementation of next generation sequencing of cancer and correlation with clinical status 2. Molecular profiling and discovery of molecular markers in ductal carcinoma in-situ of breast 3. Implementation of genotype guided decision making into clinical workflow

Selected Publications 
Wolff B, Harada S. Molecular pathology and molecular markers of ductal carcinoma in-situ. Current Cancer Therapy Reviews, 8(3), 197-204, 2012.   
Jarett L, Harada S, Lee Y-H, Smith JA, Shah N, Zhang S, Smith RM. Insulin endocytosis and other alternative pathways in the insulin signal transduction network. Antibody, Immunoconjugates, and Radiopharmaceuticals 8: 251-259, 1995.    
Harada S, Gocke CD. Pathology Case Review: Specimen identity testing using DNA analysis in clinical and surgical pathology setting. Pathology Case Reviews 15:116-120, 2010.    
First Prev   1 2 of  2  Next Last  

Keywords
molecular pathology, breast pathology, precision medicine